File regulatory submissions for brensocatib in the EU, UK, and Japan
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 6 Feb 2025
- Due
- 31 Dec 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Insmed plans to file regulatory submissions for brensocatib in the EU, UK, and Japan in 2025”
What we found
Evidence strength A What the grades mean
Insmed filed brensocatib regulatory submissions in the EU and UK by mid-2025, and Japan's application was accepted by Q3 2025, all within the 2025 deadline.
-
A INSMED Inc - Form ARS - FY2025 Annual Report Company states it filed for approval in UK, EU, and Japan in 2025
-
B Insmed Reports First-Quarter 2025 Financial Results EU and UK submissions accepted; Japan submission planned for 2025
-
B Insmed Reports Second-Quarter 2025 Financial Results EU/UK submissions accepted; Japan submission planned for H2 2025
-
D Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update Headline states Japan application accepted; positive CHMP opinion in EU
Checked 15 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- File
- Language
- Expected (“expects”, “plans”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesGemini (Google) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Insmed Inc? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-INSM-000333 · Corrections policy